This page contains the titles and 1st authors of all posters that will be presented at the conference. The full abstracts and author information are included in the abstract book.

 – Click here for the complete SIPS 2019 abstract book – 

Poster Session 1. Sunday, July 7, 6:00 PM – 7.30 PM

1.01 – Christoph Werner – The development and evaluation of a new model of an active placebo

1.02 – Kelly Clemens – Momentary mood as a moderator of verbally-induced placebo analgesia in an experimental pain paradigm

1.03 – Damien Boorman – Serotonergic neurons in the rostral midline medulla are activated by placebo-induced analgesia in rats with chronic neuropathic pain

1.04 – Karina Hansen – Active effects and placebo effects of a mindfulness based psychological intervention

1.05 – Annelie Göhler – Relieving sad mood – Can a placebo be of help?

1.06 – Arran Davis – Ergogenic placebo and social support effects on muscle work and fatigue in an fMRI-compatible experiment

1.07 – Sean Zion – Leveraging patient mindsets to harness the clinical utility of the placebo effect in modern medicine

1.08 – Aleksandrina Skvortsova – Can oxytocin influence placebo and nocebo effects?

1.09 – Yiqi Pan – Minimizing drug adverse events by informing about the nocebo effect – An experimental proof-of-concept study with headache patients

1.10 – Antje Frey Nascimento – Open-label placebo treatment for women suffering from premenstrual syndrome: Study protocol and first results of a randomized controlled trial

Poster Session 2. Monday, July 8, 1:00 PM – 2.00 PM

2.01 – Elisabeth Olliges – Open-label placebos for elderly patients with chronic knee pain: Effects on pain, functionality, and quality of life

2.02 – Giacomo Rossettini – Knowledge of contextual factors, placebo and nocebo effects in patients with musculoskeletal pain: A national survey

2.03 – Alvisa Palese – Knowledge, beliefs, use, and ethical and communicational issues of placebo and nocebo effects among nursing students: A national survey

2.04 – Marco Testa – Contextual factors triggering placebo and nocebo effects in Italian nursing practice: A national cross-sectional study

2.05 – Lotte van Dillen – A taste of the (un)expected

2.06 – Seetal Dodd – Incidence and characteristics of the nocebo response from meta-analyses of the placebo arms of clinical trials

2.07 – Alexandra Kern – The influence of personality traits on the placebo/nocebo response: A systematic review

2.08 – Solene Frileux – The placebo diet: How suggestion affects cognitive regulation, and through it hunger perception

2.09 – Michael Schaefer – Open-label placebos improve test anxiety and self-management abilities and resources

2.10 – Paul Dieppe – Therapeutic landscapes and atmospheres: Important components of context effects in healthcare

2.11 – Anne Schienle – Placebo effects in spider phobia: An eye-tracking experiment

2.12 – Alexander Winkler – Placebo- and nocebo- effects in cognitive neuroenhancement: Expectation affects perceived but not actual cognitive performance

2.13 – Rosanne Smits – The role of placebo effects in immune-related conditions: Mechanisms and clinical considerations

2.14 – Elisa Kamper-Fuhrmann – Investigating placebo responses in preschoolers (≤ 6 y): Challenging but possible?

2.15 – Regula Neuenschwander – Investigating parents’ approaches of how to shape their children’s mind: A pilot study on harnessing placebo effects in day-to-day life

2.16 – Kirsten Barnes – I’m trying to tell you: Open label placebo effects in GVS and VR-induced nausea

2.17 – Sarah Theiss – An exploration of the role of context effects in acupuncture practice: A qualitative study based on semi-structured interviews with acupuncturists in private practice in three different locations

2.18 – Julia Schmitz – Positive treatment expectancies reduce clinical pain and perceived motor disability despite increased pain experience: A randomized controlled trial on sham opioid infusion in patients with chronic back pain

2.19 – Jianyou Guo – An animal model of placebo analgesia in inflammatory pain rats

2.20 – Uri Nitzan – Open-label placebo for the treatment of depression – A randomized controlled trial

2.21 – Younbyoung Chae – How placebo needles differ from placebo pills?

2.22 – Anne-Kathrin Bräscher – Aiming for placebo and (partly) observing nocebo: A pilot study on open-label placebo

2.23 – Amelia Scott – The blind leading the not-so-blind: A meta-analysis of blinding in pharmacological trials for chronic pain

2.24 – Sandhya Ravikumar – The placebo response in migraine treatment trials: Comparing oral preventives, botulinum toxin, and anti-CGRP treatments

2.25 – Victoria Bridgland – Expecting the worst: Investigating the effects of trigger warnings on reactions to ambiguously themed photos

2.26 – Sophie Kjær – The role of expectations in placebo analgesia: A meta-analysis

2.27 – Roel Gaymans – Selfhealing and the placebo effect

2.28 – Thilo Friehs – How to administer deceptive and open-label placebos? A five-armed experimental study on sadness

2.29 – Elżbieta Bajcar – Do we learn pain better from people like us? Observational learning in inducing placebo analgesia

2.30 – Bernardo Villa-Sánchez – Positive verbal suggestions optimize postural control

2.31 – Ewa Buglewicz – Is pain contagious? The effect of observation on pain induction and its influence on placebo studies

2.32 – Liesbeth van Vliet – The use of empathy and expectancy manipulations to counter nocebo-effects of information provision in palliative cancer care; An observational study of clinician-patient consultations

2.33 – Jarry Porsius – Factors influencing patient outcome expectations in daily clinical practice

2.34 – Helen Köchlin – Common factors in the treatment of chronic primary pain in children and adolescents: Protocol for a network meta-analysis

2.35 – Jens Hamberger – Placebo economics – The economic potential of utilizing the placebo effect in drug therapy

2.36 – Daniela Schelski – Marketing placebo effects on taste perception are not related to the level of trust in marketers and not affected by oxytocin

2.37 – Lisa D’Astolfo – No1likesu – An experimental paradigm to investigate social expectations and their adjustment

2.38 – Carmen Jacob – Prediction of placebo responsiveness in motion sickness by the cognitive reflection test – Are placebo responders more intuitive?

2.39 – Eleonora Maria Camerone – The time component of expectation in placebo analgesia

2.40 – Nathan Huneke – Belief about group allocation predicts placebo response in the 7.5% carbon dioxide inhalational model of anxiety

2.41 – Lemmy Schakel – Can verbal suggestions strengthen the effects of a relaxation intervention?

2.42 – Mariève Cyr – Inducing placebo psychedelic experiences by manipulating contextual factors

2.43 – Johannes Laferton – Expectation effects on surgery outcome in hip and knee arthroplasty: A meta-analysis

2.44 – Marta Ceko – Predicting placebo analgesia – New approaches combining personality, brain and genetics in large-scale samples

2.45 – Stefanie Meeuwis – Can placebo effects be learned for histamine-induced itch? Conditioning the effects of antihistamines

2.46 – Cláudia Carvalho – Open label placebo in chronic low back pain: A follow up study

2.47 – Merve Karacaoglu – Nocebo effects on pressure pain: Their induction and reduction via learning

2.48 – Judith Tekampe – Randomized controlled trial on conditioning cortisol and its psychophysiological effects

2.49 – Meriem Manaï – The role of conditioning for pharmacological treatments in rheumatoid arthritis: A pilot study

2.50 – Heike Gerger – Hospital clowning – A psychological placebo intervention?

2.51 – Joseph Blythe – Manipulating NMDA-dependent learning to alter nocebo effects on itch: Experimental design

Poster Session 3. Tuesday, July 9, 1:00 PM – 2.00 PM

3.01 – Paul Dieppe – Do placebos cause an aggravation response?

3.02 – Karolina Wiercioch-Kuzianik – Placebo analgesia: The interplay between classical conditioning and verbal suggestions. Results from a comprehensive, multi-group study

3.03 – Efrat Czerniak – Placebo by proxy: Parent’s role in child’s medical treatment

3.04 – Elisa Frisaldi – The placebo response in myasthenia gravis: A meta-analysis

3.05 – Valentin Panayotov – Studying a possible placebo effect of an imaginary low-calorie diet

3.06 – LingLing Weng – Do placebo and nocebo effects generalize across somatosensory sensations?

3.07 – Meike Shedden-Mora – The Treatment Expectation Questionnaire (TEX-Q) – A generic multidimensional scale measuring patients’ treatment expectations

3.08 – Dominika Farley – Nocebo hyperalgesia: The interplay between classical conditioning and verbal suggestions. Results from a comprehensive, multi-group study

3.09 – Philip Hurst – An educational placebo effect intervention reduces the likelihood of athletes using performance enhancing drugs

3.10 – Ryan van Nood – Faces and masks of the placebo effect: Open-label placebos and the mind-body problem

3.11 – Cora Wagner – Animal-assisted placebo intervention: Can the presence of a dog affect placebo analgesia?

3.12 – Rosanne Smits – Explaining the placebo effect: Does ‘Pavlov’ ring a bell?

3.13 – Simone Meijer – Counterconditioning as treatment for chronic pain symptoms: A study design

3.14 – Helena Bieniek – Does social status matter when it comes to learning pain from others? A study on observational learning in inducing placebo analgesia

3.15 – Fabian Wolters – Evoking placebo and nocebo effects on mental fatigue

3.16 – Roel van Dooren – Shifting the balance: The role of context in shaping metacontrol policies.

3.17 – Waclaw Adamczyk – Nocebo effect in experimental paraesthesia

3.18 – Yvonne Nestoriuc – Discontinuing antidepressants and antipsychotics: An online survey of consumers’ experiences and expectations

3.19 – Yang Wang – The influences of observational learning on pain perception and its neural correlates

3.20 – Liat Honigman – Pain reporting accuracy and the placebo response

3.21 – Ehab Matta – Can training aimed to increase pain-reporting accuracy diminish the placebo response?

3.22 – Julia Stuhlreyer – Patient–clinician relationship as an “add-on” to drugs?  Empathic clinician visits impacts the success of the perioperative pain therapy (RCT)

3.23 – Merve Karacaoglu – The role of nocebo effects in identifying patients at risk for pain sensitization in fibromyalgia: A study design

3.24 – Mia Thomaïdou – Neurophysiological underpinnings of nocebo hyperalgesia: Current findings and future directions.

3.25 – Titilola Akintola – Novel race effects on expectancy-induced analgesia in temporomandibular joint disorder

3.26 – Soyeon Cheon – Association of information disclosure on placebo control with blinding and trial outcomes – A case study of participant information leaflets of randomised placebo-controlled trials of acupuncture

3.27 – Felicity Braithwaite – Blinding in physical intervention research: A framework for sham development

3.28 – Joseph Blythe – Nocebo effects on cowhage-evoked itch: The role of conditioning and observational learning

3.29 – Nadja Heimgartner – Open/hidden administration of exposure training in spider phobia

3.30 – Dieuwke Veldhuijzen – The role of expectations in conditioned pain modulation

3.31 – Stefan Salzmann – Moderators and mediators of a preoperative psychological intervention aiming at improving heart surgery outcomes – the PSY-HEART I trial

3.32 – Alexandra Tinnermann – Does expectancy increase analgesia during opioid treatment?

3.33 – Marcel Wilhelm – Open-label placebo vs. conventional and alternative medicine – An online study on expected effectiveness

3.34 – Henriët van Middendorp – Expectancies as predictors of symptom improvement in patients with persistent symptoms attributed to Lyme disease

3.35 – Meriem Manaï – Conditioning the effects of a stress management intervention to a distinctive scent

3.36 – Kaitlyn Matthews – ‘At face value’: General practitioners’ attitudes toward placebos and open-label placebos

3.37 – Carmen-Édith Belleï-Rodriguez – Placebo effect and cognitive ability in children with attention deficit hyperactivity disorder

3.38 – Dilan Sezer – The role of expectancy and adherence on open-label placebo effects in premenstrual syndrome: Preliminary results of a randomized controlled trial

3.39 – Sarah Bürgler – Open-label placebo in premenstrual syndrome: Preliminary results of a randomized controlled trial on psychological distress, functional interference and health-related quality of life

3.40 – Philipp Reicherts – Placebo manipulations influence the effectiveness of pain regulation

3.41 – Huib van Dis – Statin intolerance: Biological toxicity or nocebo-effect?

3.42 – Danielle Bartels – Nocebo effects and scratching behaviour on itch

3.43 – Attila Szabo – Improved affect and physical wellbeing after only three minutes:  The power of an active- and a pure placebo pill

3.44 – Dhahyun Choi – Brain activations in the expectations of sensory experience for acupuncture stimulation

3.45 – Akbar Shabir – The influence of caffeine expectancies on simulated soccer performance

3.46 – Mette Sieg – Patient attitudes towards adverse event disclosure

3.47 – Stefanie Meeuwis – Open- and closed-label verbal suggestions regarding a sham transdermal caffeine patch: Effects on itch

3.48 – Justyna Brączyk – The self-confidence of a model – Can it modulate the strength of learning about pain? A study on placebo analgesia induced by observational learning.

3.49 – Michael Bernstein – Evaluating the feasibility of adjunctive open-placebos for acute pain: A pilot study

3.50 – Davide Anchisi – Order matters: Pain experience and expectation continuously shape perception

3.51 – Jonathan Ashar – Open-label placebo injection for chronic back pain:  A randomized controlled trial

3.52 – Elizabeth Olson – Sex influence on expectancy and placebo analgesia in chronic orofacial pain patients

3.53 – Felicity Bishop – A research protocol for empathy and expectation management for patients in primary care: Methods for developing a new digital intervention for practitioners